Market position Leverage Mawdsleys’ status as the UK’s largest independent NHS secondary care distributor and largest importer of unlicensed medicines to propose expanded contract services, faster access programs, and strategic logistics partnerships with healthcare providers seeking reliable medicine flow and compliance.

Expansion leverage Target opportunities around their growing network and facilities, such as warehousing and transport services, to offer enhanced cold chain, inventory management, and cross-border distribution for international subsidiaries and UK hospitals undergoing capacity expansion.

Digital enablement Utilize their tech stack and active digital footprint to introduce integrated procurement platforms, supplier portals, and automated compliance workflows that streamline ordering, invoicing, and regulatory documentation for NHS and hospital systems.

Named Patient potential Explore partnerships or fee-for-service programs around Named Patient Supply and unlicensed access, aligning with oncology and rare-disease demand, while offering risk-managed supply continuity and regulatory navigation services.

International footprint Develop cross-border supply chain services and regulatory support for their Israel, Brazil, and Belgium subsidiaries, including import/export optimization, local market entries, and regional contract manufacturing or distribution collaborations for global pharma clients.